Home
Conditions
Tyrosine Kinase Inhibitor

Clinical trial condition

Tyrosine Kinase Inhibitor

Explore clinical trials studying Tyrosine Kinase Inhibitor. Study availability and eligibility vary by location and protocol.

15 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

Tyrosine Kinase Inhibitor trial results

Recruiting

The TASTY-training Study

NCT07258589

Conditions: Oncological Patients, Tyrosine Kinase Inhibitor
Locations: Amsterdam UMC Amsterdam, Netherlands

Rijnstate Ziekenhuis Arnhem, Netherlands

Van Weel-Bethesda Ziekenhuis Dirksland, Netherlands

Ziekenhuisvoorzieningen Gelderse Vallei Ede, Netherlands

View Trial Details

Recruiting

A Potential Relationship Between Treatment With Tyrosine Kinase Inhibitors and Erectile Dysfunction in Male Patients With Chronic Myeloid Leukemia

NCT07061145

Conditions: Bone Marrow Diseases, CVD - Cardiovascular Disease, Cardiovascular Diseases, +23 more
Locations: Azienda USL IRCCS di Reggio Emilia Reggio Emilia, RE, Italy

View Trial Details

Recruiting

Firmonertinib Combined With Intrathecal Injection for the Treatment of EGFR Mutant NSCLC With Leptomeningeal Metastases

NCT07092202

Conditions: Central Nervous System Neoplasms, Intrathecal Chemotherapy, Leptomeningeal Metastasis, +8 more
Locations: Wuhan Union Hospital Wuhan, Hubei, China

View Trial Details

Recruiting

Neoadjuvant Befotertinib Combined Bevacizumab or Platinum-based Double Chemotherapy for Resectable Locally-advanced EGFR Mutation-positive Non-Small Cell Lung Cancer

NCT06755684

Conditions: Antineoplastic Agents, Bevacizumab, Bronchial Neoplasms, +15 more
Locations: Shanghai Pulmonary Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

ProSpecTive sAmpling in dRiver muTation Pulmonary Oncology Patients on Tyrosine Kinase Inhibitors (START-TKI)

NCT05221372

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: Erasmus MC Rotterdam, Netherlands

View Trial Details

Not Yet Recruiting

Anlotinib Plus Nab-Paclitaxels and S-1 for Patients with Advanced Biliary Tract Cancer As Second-Line Treatment

NCT06662877

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +7 more
Locations: The First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Olverembatinib as Maintenance Therapy or Preemptive Therapy After Allo-HSCT in Ph+ALL

NCT06658925

Conditions: HSCT, Ph+ Acute Lymphoblastic Leukemia (Ph+ALL), Tyrosine Kinase Inhibitor
Locations: Not specified

View Trial Details

Not Yet Recruiting

SBRT Combined With Adbelimumab and Apatinib for Perioperative and Conversion Therapy of Hepatocellular Carcinoma

NCT06538935

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations: Not specified

View Trial Details

Completed

Bevacizumab Combined With Double Doses of Icotinib in Advanced NSCLC Patients With EGFR L858R Mutation

NCT05263947

Conditions: Bevacizumab, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations: Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Completed

Effect of Pre-Transplant Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma Patients With Liver Transplantation

NCT07418138

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations: First Affiliated Hospital Xian Jiaotong University Xi'an, Shaanxi, China

View Trial Details

Tyrosine Kinase Inhibitor

Tyrosine Kinase Inhibitor trial results

Related conditions